glp-1 and lamotrigine Can GLP-1s Help People With Bipolar Disorder? Lemme GLP-1 Daily: Supresa-Based GLP-1

GIP (Glucose-dependent Insulinotropic Polypeptide): Another incretin hormone produced in the intestines Stimulates insulin secretion from the pancreas Enhances fat metabolism Affects how the body stores and uses energy May amplify the appetite-suppressing effects of GLP-1 The Combined Effect: When both GLP-1 and GIP pathways are activated together: Stronger insulin response: better blood sugar control Enhanced fat burning: greater weight loss More appetite suppression: reduced food intake Slower gastric emptying: prolonged fullness (and potential problems) Clinical Advantages of Tirzepatide Greater Weight Loss: Clinical trials showed tirzepatide produced: Average weight loss: 20-25% of body weight Compared to semaglutide: 15-20% Some patients lost 30%+ of their starting weight Faster Results: Many patients report: Quicker onset of appetite suppression More rapid weight loss in the first months Stronger fullness sensation after meals Superior Glucose Control: For diabetic patients: Greater A1C reductions than semaglutide More patients reaching target A1C goals Fewer patients needing additional diabetes medications Potential Disadvantages and Risks 1

Understanding these differences helps guide individualized management strategies, which are critical for maintaining adherence and optimizing outcomes

Integrate Resistance Training and Protein Repletion Encourage progressive resistance training and adequate protein intake to protect muscle mass and bone density during rapid weight reduction

Diarrhea is more common during dose escalation phases and usually resolves within one to two weeks